Claims
- 1. A method of assessing the viability of a spore after a sterilization treatment, comprising:
(a) exposing a spore to a sterilization treatment; (b) examining the treated spore using multiangle light scattering; and (c) evaluating a difference between the multiangle light scattering of the treated spore and a multiangle light scattering of a like spore not exposed to a sterilization treatment to evaluate a change in spore morphology to determine whether the treated spore is viable.
- 2. The method of claim 11, wherein the spore and the like spore are selected from the group consisting of a B. subtilis spore, and a B. stearothennophilus spore.
- 3. The spore of claim 12, wherein the spore and the like spore are B. subtilis.
- 4. The spore of claim 12, wherein the spore and the like spore are B. stearothennophilus.
- 5. The method of claim 11, wherein the sterilization treatment is selected from the group consisting of a chemical sterilization treatment, and a physical sterilization treatment.
- 6. The method of claim 15, wherein the chemical sterilization treatment is selected from the group consisting of an ethylene oxide sterilization treatment, a hydrogen peroxide sterilization treatment, a tetrasilver tetraoxide sterilization treatment, and an ozone sterilization treatment.
- 7. The method of claim 15, wherein the physical sterilization treatment is selected from the group consisting of a radiation sterilization treatment, a gas plasma sterilization treatment, a steam sterilization treatment, and a dry heat sterilization treatment.
- 8. The method of claim 11, further comprising examining the like spore using multiangle light scattering prior to the sterilization treatment of the spore in step (a) to provide a standard multiple light scattering data set for use as the multiangle light scattering of the like spore in step (c).
- 9. The method of claim 18, further comprising storing the standard multiangle light scattering data to assess viability of a second like spore after sterilizing the second like spore using the sterilization treatment of step (a).
- 10. The method of claim 11, further comprising incubating the treated spore with a growth medium prior to step (b).
- 11. The method of claim 20, wherein the growth medium is selected from the group consisting of trypticase soy broth, nutrient broth, and brain heart infusion broth.
- 12. The method of claim 20, further comprising incubating the spore up to about 24 hours prior to step (b).
- 13. The method of claim 20, further comprising heat-shocking the treated spore prior to incubating the treated spore with the growth medium.
- 14. The method of claim 11, wherein the sterilization treatment is selected from the group consisting of a steam sterilization treatment, and an ozone sterilization treatment, and the method further comprises examining the treated spore directly after the sterilization treatment.
- 15. A kit for assessing the viability of a spore after a sterilization treatment, the kit comprising about 2×108 spores absorbed onto a solid support, a multiangle light scattering photometer, and a liquid medium, and instructional material for determining the viability of the spore by evaluating a change in spore morphology.
- 16. The kit of claim 37, further comprising an instructional material for the use of the kit.
- 17. The kit of claim 37, wherein the liquid medium is water.
- 18. A method of determining the effectiveness of a sterilization treatment comprising:
(a) exposing a spore to the sterilization treatment; (b) examining the morphology of the treated spore using multiangle light scattering; and (c) evaluating a difference between the morphology of the treated spore and the morphology of a like spore not exposed to a sterilization treatment, to determine whether the treated spore is viable.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority as a continuation application to U.S. patent application Ser. No. 10/091,260, filed Mar. 4, 2002, presently pending, which in turn claims the benefit of priority to U.S. patent application Ser. No. 09/563,707, filed May 2, 2000 (now abandoned), which in turn claim the benefit of priority under 35 U.S.C. § 119(e) to U.S. provisional patent application serial No. 60/132,186, filed May 3, 1999, the contents of each of which are incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60132186 |
May 1999 |
US |
Continuations (1)
|
Number |
Date |
Country |
| Parent |
10091742 |
Mar 2002 |
US |
| Child |
10720576 |
Nov 2003 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
| Parent |
09563707 |
May 2000 |
US |
| Child |
10091742 |
Mar 2002 |
US |